Clinical Trial Update: A Clinical Study of the Safety and Activity of the Investigational Cell Therapy NEO-PTC-01 in Patients With Advanced Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and activity of BioNTech's investigational cell therapy NEO-PTC-01 in patients with unresectable or metastatic melanoma ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• NEO-PTC-01

Snippet

Sponsor: BioNTech US Inc. | Conditions: Unresectable Melanoma, Metastatic Melanoma | Phase 1 | Status: TERMINATED